Randomized controlled trial of Fluoxetine or placebo on quality of life after acute ischemic stroke.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20181216001

Enrollment

Registered

2018-12-16

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Matching placebo once daily for 90 days ,Fluoxetine 20 mg once daily for 90 days

Placebo Comparator Drug,Experimental Drug

Placebo,Fluoxetine

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: - consenting - age > 18 - acute ischemic stroke patient

Exclusion criteria

Exclusion criteria: - history of or current psychiatric condition - hemorrhagic complication - EQ-5D-5L score > 0.9 - language barrier

Design outcomes

Primary

Measure	Time frame
Quality of life 3 months EQ-5D-5L ,Post stroke depression 3 months Thai HADS	—

Secondary

Measure	Time frame
Post stroke depression 3 months Thai HADS,Disability 3 months Modified Rankin Score	—

Countries

Thailand

Contacts

Public ContactSirikanya Lorwatanapongsa

Bhumibol Adulyadej Hospital

sirikanyalor@yahoo.com0898973221

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026